Cover of: Trends in serotonin uptake inhibitor research | Read Online

Trends in serotonin uptake inhibitor research

  • 271 Want to read
  • ·
  • 35 Currently reading

Published by Nova Science Pub. in Hauppauge, NY .
Written in English


  • Serotonin uptake inhibitors.

Book details:

Edition Notes

Includes bibliographical references and index.

StatementAnne C. Shirley (editor).
ContributionsShirley, Anne C.
LC ClassificationsRM332 .T73 2004
The Physical Object
Paginationp. cm.
ID Numbers
Open LibraryOL3400352M
ISBN 101594543380
LC Control Number2005014599

Download Trends in serotonin uptake inhibitor research


  Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed antidepressants. Other clinical indications for SSRI use include anxiety disorders, obsessive-compulsive disorder, panic disorders, and eating disorders. Compared to their predecessors, the monoamine oxidase inhibitors and tricyclic antidepressants, SSRIs are associated with fewer toxic effects.[1]Author: Clare Bruggeman, Carla S. O'Day. View Serotonin Uptake Inhibitors Research Papers on for free. Focus on serotonin re uptake inhibitors research / Hani Raoul Khouzam --Anxiety status in school refusal children with indefinite complaints: psychological evaluation using state-trait anxiety inventory (STAI) and therapeutic potential by selective serotonin reuptake inhibitors (SSRIs) / Ryoichi Sakuta [and others] HT2a antagonists for the. Thomas Blom, Rutger Meinsma, Marja Rutgers, Corine Buitenhuis, Marieke Dekken-Van den Burg, André B. P. van Kuilenburg, Godelieve A. M. Tytgat, Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake, EJNMMI Research, /sw,

Background: Depression is characterized by low mood, low self-esteem, and loss of interest or pleasure. Painful physical symptoms (PPS) associated with depression have a negative impact on the probability of remission. Because both norepinephrine and serotonin are involved with the central regulation of pain, the serotonin-norepinephrine reuptake inhibitors (SNRIs) may have more success than.   A comparison of benzodiazepines and selective serotonin re-uptake inhibitors: SSRi and dependence. Addiction ; (5): –8. 13 Davies, J, Read, J. Serotonin syndrome. Rarely, an antidepressant can cause high levels of serotonin to accumulate in your body. Serotonin syndrome most often occurs when two medications that raise the level of serotonin are combined. These include, for example, other antidepressants, certain pain or headache medications, and the herbal supplement St. John's wort. The use of antidepressants such as selective serotonin reuptake inhibitors (SSRIs) in the United States markedly increased from % in to % in 1 From to , approximately 1 in 8 persons aged 12 years or older reported taking an antidepressant in the previous month. 1 According to the National Ambulatory Medical Care Survey, antidepressants are the third most.

The hypothesis that serotonin hypofunction might be implicated in certain forms of depressive illness provided the impetus to design selective inhibitors of sodium-ion coupled serotonin uptake. A number of these compounds have subsequently been developed and . Venlafaxine is a potent serotonin re-uptake inhibitor, so it is not surprising that it has been associated with serotonin-related symptoms in neonates.. A boy was born by forceps delivery at 39 weeks gestation to a year-old woman who had been taking venlafaxine mg/day (26 A).He failed to feed properly, had vomiting, and after 24 hours developed multifocal myoclonic seizures. Selective serotonin re-uptake inhibitor warnings and trends in exposures reported to poison control centres in Texas Article in Public Health (12) August with 25 Reads. Selective serotonin reuptake inhibitors (SSRIs) elevate the extracellular level of neurotransmitters known as serotonin by inhibiting its uptake in presynaptic cells. Therefore, selective serotonin reuptake inhibitors are widely used as medication for the treatment of severe or persistent depression.